ペンシルベニアにおけるループスの臨床試験
ペンシルベニア内の拠点で、ループスに関する14件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University Of Pittsburgh, Pittsburgh
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/10/01更新 · NCT06133972Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Temple University, Philadelphia
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research, Duncansville
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/10/01更新 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Philadelphia
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/30更新 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Clinical Research Philadelphia, Philadelphia
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中第1/2相
10歳〜29歳 · 全性別 · 2026/09/24更新 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Fox Chase Cancer Center- Temple BMT, Philadelphia
被験者募集中第2相
16歳〜70歳 · 全性別 · 2026/09/17更新 · NCT07328581A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50365, Pittsburgh
被験者募集中第3相
16歳以上 · 全性別 · 2026/09/04更新 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0075, Philadelphia
- Local Institution - 0052, Philadelphia
被験者募集中観察研究
16歳以上 · 全性別 · 2026/09/03更新 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/08/26更新 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Penn State MS Hershey Medical Center, Hershey
被験者募集中第3相
55歳以上 · 全性別 · 2026/08/20更新 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
被験者募集中第1相
12歳〜70歳 · 全性別 · 2026/05/22更新 · NCT06308978Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中第2相
8歳〜25歳 · 全性別 · 2025/10/14更新 · NCT05029336ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。